Cargando…
Competition in the German pharmacy market: an empirical analysis
BACKGROUND: Pharmaceutical products are an important component of expenditure on public health insurance in the Federal Republic of Germany. For years, German policy makers have regulated public pharmacies in order to limit the increase in costs. One reform has followed another, main objective being...
Autores principales: | Heinsohn, Jörg G, Flessa, Steffen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856528/ https://www.ncbi.nlm.nih.gov/pubmed/24112461 http://dx.doi.org/10.1186/1472-6963-13-407 |
Ejemplares similares
-
Economic burden of multidrug-resistant bacteria in nursing homes in Germany: a cost analysis based on empirical data
por: Huebner, Claudia, et al.
Publicado: (2016) -
Analysis of processes and costs of alternative packaging options of sterile goods in hospitals – a case study in two German hospitals
por: Krohn, Markus, et al.
Publicado: (2019) -
An empirical study of the impact of generic drug competition on drug market prices in China
por: Yina, Chen, et al.
Publicado: (2023) -
Cost of diagnosing dementia in a German memory clinic
por: Michalowsky, Bernhard, et al.
Publicado: (2017) -
Costing of helicopter emergency services- a strategic simulation based on the example of a German rural region
por: Röper, Johann, et al.
Publicado: (2020)